Researchers have developed two distinct, highly innovative AST methods for directly measuring a pathogen's susceptibility to beta-lactams on very short time scales
Clinical studies are needed to determine whether early therapeutic interventions prolong survival times and improve quality of life
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.